Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
25,847,132
-
Share change
-
+25,847,132
-
Total reported value
-
$346,639,000
-
Put/Call ratio
-
23%
-
Price per share
-
$13.55
-
Number of holders
-
49
-
Value change
-
+$346,639,000
-
Number of buys
-
49
Institutional Holders of GEMINI THERAPEUTICS INC - COM (GMTX) as of Q1 2021
As of 31 Mar 2021,
GEMINI THERAPEUTICS INC - COM (GMTX) was held by
49 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,847,132 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, FMR LLC, Foresite Capital Management V, LLC, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, SUVRETTA CAPITAL MANAGEMENT, LLC, BOXER CAPITAL, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Opaleye Management Inc., and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
49
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.